BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 26703550)

  • 21. Combination of low dose of genistein and daidzein has synergistic preventive effects on isogenic human prostate cancer cells when compared with individual soy isoflavone.
    Dong X; Xu W; Sikes RA; Wu C
    Food Chem; 2013 Dec; 141(3):1923-33. PubMed ID: 23870911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Down-regulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 expression by soy isoflavones enhances prostate cancer radiotherapy in vitro and in vivo.
    Raffoul JJ; Banerjee S; Singh-Gupta V; Knoll ZE; Fite A; Zhang H; Abrams J; Sarkar FH; Hillman GG
    Cancer Res; 2007 Mar; 67(5):2141-9. PubMed ID: 17332344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genistein suppresses proliferation and MET oncogene expression and induces EGR-1 tumor suppressor expression in immortalized human breast epithelial cells.
    Singletary K; Ellington A
    Anticancer Res; 2006; 26(2A):1039-48. PubMed ID: 16619504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soy protein extract (SPE) exhibits differential in vitro cell proliferation effects in oral cancer and normal cell lines.
    Kingsley K; Truong K; Low E; Hill CK; Chokshi SB; Phipps D; West MA; Keiserman MA; Bergman CJ
    J Diet Suppl; 2011 Jun; 8(2):169-88. PubMed ID: 22432688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Soy Isoflavones in Integrative Oncology: Increased Efficacy and Decreased Toxicity of Cancer Therapy.
    Sahin I; Bilir B; Ali S; Sahin K; Kucuk O
    Integr Cancer Ther; 2019; 18():1534735419835310. PubMed ID: 30897972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Soy and its isoflavones: the truth behind the science in breast cancer.
    Douglas CC; Johnson SA; Arjmandi BH
    Anticancer Agents Med Chem; 2013 Oct; 13(8):1178-87. PubMed ID: 23919747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Equol, an isoflavone metabolite, regulates cancer cell viability and protein synthesis initiation via c-Myc and eIF4G.
    de la Parra C; Borrero-Garcia LD; Cruz-Collazo A; Schneider RJ; Dharmawardhane S
    J Biol Chem; 2015 Mar; 290(10):6047-57. PubMed ID: 25593313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigating the Antiangiogenic, Anti-drug Resistance and Apoptotic Effects of Soy Isoflavone Extract Alone or in Combination with Docetaxel on Murine 4T1 Breast Tumor Model.
    Hejazi E; Tavakoli M; Jeddi-Tehrani M; Kimiagar M; Hejazi J; Houshyari M; Amiri Z; Edalatkhah H; Nasrollahzadeh J; Idali F
    Nutr Cancer; 2017 Oct; 69(7):1036-1042. PubMed ID: 28937793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antitumor and antiangiogenic activity of soy phytoestrogen on 7,12-dimethylbenz[alpha]anthracene-induced mammary tumors following ovariectomy in Sprague-Dawley rats.
    Kang X; Jin S; Zhang Q
    J Food Sci; 2009 Sep; 74(7):H237-42. PubMed ID: 19895476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can the combination of flaxseed and its lignans with soy and its isoflavones reduce the growth stimulatory effect of soy and its isoflavones on established breast cancer?
    Power KA; Thompson LU
    Mol Nutr Food Res; 2007 Jul; 51(7):845-56. PubMed ID: 17579892
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of different lignans and isoflavones, tested as aglycones and glycosides, on hormone receptor-positive and -negative breast carcinoma cells in vitro.
    Theil C; Briese V; Gerber B; Richter DU
    Arch Gynecol Obstet; 2011 Aug; 284(2):459-65. PubMed ID: 20821227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isoflavones made simple - genistein's agonist activity for the beta-type estrogen receptor mediates their health benefits.
    McCarty MF
    Med Hypotheses; 2006; 66(6):1093-114. PubMed ID: 16513288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apoptotic effects of cooked and in vitro digested soy on human prostate cancer cells.
    Dong X; Xu W; Sikes RA; Wu C
    Food Chem; 2012 Dec; 135(3):1643-52. PubMed ID: 22953905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis of novel isoflavene-propranolol hybrids as anti-tumor agents.
    Yee EM; Pasquier E; Iskander G; Wood K; Black DS; Kumar N
    Bioorg Med Chem; 2013 Apr; 21(7):1652-60. PubMed ID: 23462711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Possibility of breast cancer prevention: use of soy isoflavones and fermented soy beverage produced using probiotics.
    Takagi A; Kano M; Kaga C
    Int J Mol Sci; 2015 May; 16(5):10907-20. PubMed ID: 25984609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple mechanisms of soy isoflavones against oxidative stress-induced endothelium injury.
    Xu SZ; Zhong W; Ghavideldarestani M; Saurabh R; Lindow SW; Atkin SL
    Free Radic Biol Med; 2009 Jul; 47(2):167-75. PubMed ID: 19393315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apoptosis induction of colorectal cancer cells HTL-9 in vitro by the transformed products of soybean isoflavones by Ganoderma lucidum.
    Cui ML; Yang HY; He GQ
    J Zhejiang Univ Sci B; 2017 Dec.; 18(12):1101-1112. PubMed ID: 29204990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of proto-oncogene BRF2 in breast cancer cells by the dietary soybean isoflavone daidzein.
    Koo J; Cabarcas-Petroski S; Petrie JL; Diette N; White RJ; Schramm L
    BMC Cancer; 2015 Nov; 15():905. PubMed ID: 26573593
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Soy isoflavones: are they useful in menopause?
    Vincent A; Fitzpatrick LA
    Mayo Clin Proc; 2000 Nov; 75(11):1174-84. PubMed ID: 11075748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Soy isoflavones enhance radiotherapy in a metastatic prostate cancer model.
    Raffoul JJ; Banerjee S; Che M; Knoll ZE; Doerge DR; Abrams J; Kucuk O; Sarkar FH; Hillman GG
    Int J Cancer; 2007 Jun; 120(11):2491-8. PubMed ID: 17304503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.